N-Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: Its relevance to studies of acute brain injury

Journal of Neurochemistry

Volumn 77, Issue 2, 2001, Pages 408-415

  Demougeot, Céline ^a,b   Garnier, Philippe ^a   Mossiat, Claude ^a   Bertrand, Nathalie ^a   Giroud, Maurice ^b   Beley, Alain ^a   Marie, Christine ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Aminoguanidine; Brain ischaemia; Dipyridyl; Mitochondrial poisoning; N acetylaspartate

Indexed keywords

3 NITROPROPIONIC ACID; AMINOGUANIDINE; BIPYRIDINE; MALONIC ACID; N ACETYLASPARTIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL EMBOLISM; BRAIN EDEMA; BRAIN INJURY; BRAIN TISSUE; CELL DAMAGE; CELL DEATH; CELL LOSS; CELL VOLUME; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; STRIATE CORTEX; STROKE; TISSUE NECROSIS;

2,2'-DIPYRIDYL; ACUTE DISEASE; ANIMALS; ASPARTIC ACID; BIOLOGICAL MARKERS; BRAIN CHEMISTRY; BRAIN EDEMA; BRAIN ISCHEMIA; CAROTID ARTERIES; CELL DEATH; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; GUANIDINES; INJECTIONS, INTRA-ARTERIAL; IRON CHELATING AGENTS; MALE; MALONATES; MICROSPHERES; MITOCHONDRIA; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRO COMPOUNDS; OXIDATIVE STRESS; PREMEDICATION; PROPIONIC ACIDS; RATS; RATS, WISTAR; SPECTROPHOTOMETRY, ULTRAVIOLET; SUCCINATE DEHYDROGENASE;

ANIMALIA;

EID: 0035049083     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00285.x     Document Type: Article

References (39)

1. Variable susceptibility to neurotoxicity of systemic 3-nitropropionic acid
2. Extracellular N-acetyl-aspartate as a biochemical marker of the severity of neuronal damage following experimental acute traumatic brain injury
3. 1H MRS studies in vivo
4. In vitro expression of N-acetyl aspartate by oligodendrocytes: Implications for proton magnetic resonance spectroscopy signal in vivo
5. 1H-NMR spectroscopic studies of brain
6. Brain edema and blood-brain permeability following quantitative cerebral microembolism
7. Lipid metabolism, cerebral metabolic rate, and some related enzyme activities after brain infarction in rats
8. Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid
9. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions
10. Reversible decrease in N-acetylaspartate after acute brain injury
11. 1H magnetic resonance spectroscopy imaging
12. Pronostic value of proton magnetic resonance spectroscopy in ischemic stroke
13. 1H-MRS of stroke
14. Clinical correlates of proton magnetic resonance spectroscopy findings after acute cerebral infarction
15. Inhibition of succinate dehydrogenase by malonic acid produces an 'excitotoxic' lesion in rat striatum
16. 1H magnetic resonance spectroscopic imaging
17. Comparative study of different iron-chelating agents in cold-induced brain edema
18. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy
19. N-Acetyl-aspartyl-glutamate: Regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method
20. Deleterious Ca-independent NOS activity after oxidative stress in rat striatum
21. Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid: Evaluation by magnetic resonance imaging and in vivo proton magnetic resonance spectroscopy
22. Multi-variate analysis predicts clinical outcome 30 days after middle cerebral artery infarction
23. Immunohistochemical localization of N-acetylaspartate in rat brain
24. Measurement of regional N-acetylaspartate after transient global ischemia in gerbils with and without ischemic tolerance: An index of neuronal survival
25. Ischemia-induced brain iron delocalization: Effect of iron chelators
26. Brain lactate and N-acetylaspartate in pediatric AIDS encephalopathy
27. Measurement of initial N-acetyl aspartate concentration by magnetic resonance spectroscopy and initial infarct volume by MRI predicts outcome in patients with middle cerebral artery territory infarction
28. Changes in N-acetyl-aspartate content during focal and global brain ischemia of the rat
29. Transient elevation of interstitial N-acetylaspartate in reversible global brain ischemia
30. N-Acetylaspartate distribution in rat brain striatum during acute brain ischemia
31. Astroglia contains a specific transport mechanism for N-acetyl-L-aspartate
32. Correlation between N-acetylaspartate levels and histopathologic changes in cortical infarcts of mice after middle cerebral artery occlusion
33. 3-Nitro-propionic acid induces ischemic tolerance in gerbil hippocampus in vivo
34. +
35. Investigation into the role of N-acetylaspartate in cerebral osmoregulation
36. Specific expression of N-Acetylaspartate in neurons, oligodendrocyte-type-2 astrocytes progenitors, and immature oligodendrocytes in vitro
37. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types
38. Hypoxia, the subsequent systemic metabolic acidosis, and their relationship with cerebral metabolite concentrations: An in vivo study in fetal lambs with proton magnetic resonance spectroscopy
39. 3-Nitro-propionic acid toxicity in the striatum